AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 62 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371,995 | -7.3% | 243,134 | 0.0% | 0.32% | -1.9% |
| Q2 2023 | $401,171 | +44.7% | 243,134 | 0.0% | 0.32% | +30.1% |
| Q1 2023 | $277,173 | +26.4% | 243,134 | 0.0% | 0.25% | +39.1% |
| Q4 2022 | $219,331 | -22.8% | 243,134 | 0.0% | 0.18% | -21.8% |
| Q3 2022 | $284,000 | +82.1% | 243,134 | 0.0% | 0.23% | +78.9% |
| Q2 2022 | $156,000 | -75.4% | 243,134 | 0.0% | 0.13% | -69.0% |
| Q1 2022 | $635,000 | -32.9% | 243,134 | 0.0% | 0.41% | -29.4% |
| Q4 2021 | $946,000 | -10.8% | 243,134 | 0.0% | 0.58% | -11.6% |
| Q3 2021 | $1,060,000 | +9.8% | 243,134 | 0.0% | 0.66% | +8.2% |
| Q2 2021 | $965,000 | – | 243,134 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $55,848,000 | 77.67% |
| Bracebridge Capital, LLC | 428,571 | $2,083,000 | 0.33% |
| Oak Grove Capital LLC | 89,000 | $432,000 | 0.20% |
| Perceptive Advisors | 1,750,000 | $8,496,000 | 0.12% |
| Virtu Financial LLC | 117,206 | $569,000 | 0.10% |
| WEDBUSH SECURITIES INC | 103,240 | $501,000 | 0.05% |
| J. Goldman & Co LP | 117,600 | $571,000 | 0.04% |
| Engineers Gate Manager LP | 68,300 | $332,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 118,900 | $577,000 | 0.01% |
| Brandywine Global Investment Management, LLC | 137,029 | $666,000 | 0.01% |